In a strange kind of way, with bios inherent investment risk, Anavex seems to be the best place to be if the market crashes, IMO. Even if sp drops to 4 bucks, we still have our pipeline and near term catalysts. Seems like money in the bank to me. Oh! What if the science doesn’t pan out. It already has panned out in every single Clinical Trial that we ran. Time to put on the long pants and present our case to the FDA and show them WGT.
News 
Market Data 
Discover 
AI
